Public-registry site landscape for NCT07679360, a Triple Negative Breast Cancer study sponsored by Suzhou Suncadia Biopharmaceuticals Co., Ltd.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT07679360 (registry record) |
| Sponsor | Suzhou Suncadia Biopharmaceuticals Co., Ltd. |
| Condition(s) | Triple Negative Breast Cancer |
| Phase | PHASE3 |
| Listed sites | 1 |
| Site countries | China |
Eichor generates a preliminary site-risk snapshot for NCT07679360 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →